Yahoo
OTC Markets OTCPK - Delayed Quote USD

EV Biologics, Inc. (YECO)

0.0004 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
Total Revenue
9,506.7030
Cost of Revenue
9,923.7040
Gross Profit
-14,562.4810
Selling, General and Administrative Expenses
6,083.9420
Operating Income/Expenses
6,083.9420
Total Operating Profit/Loss
-8,478.5390
Total Net Finance Income/Expense
-31.9530
Net Investment Income
62.9050
Irregular Income/Expenses
49,979.1060
Other Income/Expense, Non-Operating
-222.9480
Non-Operating Income/Expenses, Total
49,397.1700
Pretax Income
42,145.7690
Provision for Income Tax
3,063.0920
Net Income from Continuing Operations
45,208.8610
Net Income after Extraordinary Items and Discontinued Operations
45,208.8610
Net Income after Non-Controlling/Minority Interests
45,208.8610
Net Income Available to Common Stockholders
45,208.8610
Diluted Net Income Available to Common Stockholders
45,208.8610
Basic EPS
105.34
Diluted EPS
105.34
Basic Weighted Average Shares Outstanding
3,375.9080
Diluted Weighted Average Shares Outstanding
3,375.9080
Income Statement, Supplemental
EBIT
42,176.0260
EBITDA
42,747.9110
Normalized EBITDA
-7,032.2790
Normalized Income
15,340.7470
Total Unusual Items
-49,780.1900
Total Unusual Items Excluding Goodwill
-49,780.1900
Tax Effect of Unusual Items
-19,912.0760
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: